Veracyte | VCYT - Ordinary Share Capital


Veracyte reported $78.67M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Agilent USD 283.05M 540K Sep/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Bruker USD 151.72M 149.92M Sep/2025
Exact Sciences USD 189.45M 232K Sep/2025
Illumina USD 153.7M 300K Sep/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Myriad Genetics USD 93.1M 0 Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 787.07M 0 Sep/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Veracyte USD 78.67M 73K Sep/2025
Waters USD 59.52M 11K Sep/2025